聚甲和基于它们的药物成分:制剂,特性和细胞毒性
Salima T Minzanova1, Evgenii V Chekunkov1, Anna V Khabibullina1
1Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Arbuzov Str. 8, Kazan, Russia.
International journal of biological macromolecules
|January 29, 2025
概括
新的-pectin复合物 (PGKCo,PGNaCo) 显示出针对各种癌细胞的选择性抗瘤活性. 这些无毒化合物诱导细胞亡和细胞循环停止,表明瘤疾病治疗的潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
背景情况:
- 果果真衍生物正在探索治疗应用.
- 金属复合物提供了新的药理性质.
- 开发有效和选择性的抗癌药物是优先考虑的.
研究的目的:
- 为了合成新型的-pectin金属复合物:聚甲酸 (PGKCo) 和聚甲酸 (PGNaCo).
- 制备一种药理成分 (PC) PGKCo:PGNaCo (1:1) 具有潜在的抗瘤活性.
- 评估这些化合物对各种癌症细胞系的体外细胞毒性作用.
主要方法:
- 使用果果和离子合成金属复合物.
- 在人肺癌 (A549),乳腺腺癌 (MCF-7) 和宫癌 (M-HeLa) 细胞系的体外细胞活力测定.
- 对正常人细胞的毒性评估.
- 研究M-HeLa细胞的作用机制,包括细胞周期分析和通过线粒体途径诱导细胞亡.
主要成果:
- 合成的化合物 (PGKCo,PGNaCo和PC) 是水溶性的.
- 针对A549,MCF-7和M-HeLa瘤细胞系观察到选择性细胞毒性活性.
- 在正常人体细胞上没有发现显著的毒性影响.
- 药理成分 (PC) 在G0/G1阶段诱导细胞周期停止,并通过M-HeLa细胞的线粒体通路触发细胞亡.
结论:
- 新型-pectin复合物及其配方成分表现出有选择性的抗瘤特性.
- 这些化合物具有良好的安全性,对正常细胞的毒性最小.
- 这些发现表明PGKCo,PGNaCo和PC作为综合癌症治疗策略的无毒剂具有前途.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...